KNOWLEDGE PORTAL
on innovation and access to medicines

Ensuring globally equitable innovation and access to medicines is a major challenge, and is now recognised as a problem across high-, middle- and low-income countries. High prices of effective new medicines can restrict patient access and threaten the sustainability of health systems. At the same time, many health technologies urgently needed to address public health needs have not been developed or offer limited benefit over the status quo. There is growing interest in new approaches to the research & development (R&D) of health technologies that could deliver both innovation and access to medicines. Research, evidence and analysis are important for informing policymakers, analysts, advocates and the public about measures to address innovation and access challenges. However, such information is not always available, may not be easy to digest, nor readily translated into evidence-based policy. Significant gaps in the knowledge base still persist.